Phase II Single Arm Study of CABozantinib in Non-Small Cell Lung Cancer Patients with MET Deregulation (CABinMET)

被引：5
|
作者：
D'Arcangelo, M. [1 ]
Tassinari, D. [2 ]
De Marinis, F. [3 ]
Delmonte, A. [4 ]
Galetta, D. [5 ]
Cecere, F. [6 ]
Pilotto, S. [7 ]
Zanelli, F. [8 ]
Bonanno, L. [9 ]
Landi, L. [1 ]
D'Inca, F. [10 ]
Cappuzzo, F. [1 ]
机构：
[1] Azienda Usl Romagna, Oncol & Hematol, Ravenna, Italy
[2] Ausl Romagna, Rimini, Italy
[3] Ist Europeo Oncol Ircss, Milan, Italy
[4] Ist Sci Romagnolo Studio & Cura Tumori Irst, Meldola, Italy
[5] Clin Canc Ctr Giovanni Paolo Ii, Thorac Med Oncol Unit, Bari, Italy
[6] Ist Nazl Tumori Regina Elena, Rome, Italy
[7] Aou Integrata Verona, Verona, Italy
[8] Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
[9] Ist Oncol Veneto, Padua, Italy
[10] Fdn Ric Traslaz, Rome, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; MET; cabozantinib;
D O I：
10.1016/j.jtho.2019.08.1359
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-15
引用
收藏
页码：S644 / S644
页数：1
相关论文
共 50 条
  • [41] Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases
    Novello, Silvia
    Camps, Carlos
    Grossi, Francesco
    Mazieres, Julien
    Abrey, Lauren
    Vernejoux, Jean-Marc
    Thall, Aron
    Patyna, Shem
    Usari, Tiziana
    Wang, Zhixiao
    Chao, Richard C.
    Scagliotti, Giorgio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1260 - 1266
  • [42] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] A phase II study of ABT-751 in patients with advanced non-small cell lung cancer
    Mauer, Ann M.
    Cohen, Ezra E. W.
    Ma, Patrick C.
    Kozloff, Mark F.
    Schwartzberg, Lee
    Coates, Andrew I.
    Qian, Jiang
    Hagey, Anne E.
    Gordon, Gary B.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 631 - 636
  • [44] PHASE II STUDY OF WEEKLY AMRUBICIN IN PATIENTS WITH REFRACTORY OR RELAPSED NON-SMALL CELL LUNG CANCER
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Yoshioka, Hiroshige
    Kitagawa, Chiyoe
    Saka, Hideo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S875 - S875
  • [45] A phase II study with cisplatin and vinorelbine in elderly patients with advanced Non-Small Cell Lung Cancer
    Lucio, Buffoni
    Davide, Ottaviani
    Alfredo, Addeo
    Vincenzo, Dongiovanni
    Raffaella, Grillo
    Camilla, Fissore
    Carla, Barone
    Diego, Dongiovanni
    Erika, Larovere
    Oscar, Bertetto
    ANNALS OF ONCOLOGY, 2005, 16 : 27 - 27
  • [46] A phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases
    Novello, Silvia
    Abrey, Lauren
    Grossi, Francesco
    Camps, Carlos
    Mazieres, Julien
    Fain, Jerry
    Vernejoux, Jean-Marc
    Carpeno, Javier de Castro
    Selaru, Paulina
    Patyna, Shem
    Torigoe, Yasuhiro
    Chao, Richard
    Scagliotti, Giorgio
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S356 - S356
  • [47] A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer
    Fidias, P
    Supko, JG
    Martins, R
    Boral, A
    Carey, R
    Grossbard, M
    Shapiro, G
    Ostler, P
    Lucca, J
    Johnson, BE
    Skarin, A
    Lynch, TJ
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 3942 - 3949
  • [48] Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
    Paal F. Brunsvig
    Steinar Aamdal
    Marianne K. Gjertsen
    Gunnar Kvalheim
    Carrie J. Markowski-Grimsrud
    Ingunn Sve
    Marianne Dyrhaug
    Sissel Trachsel
    Mona Møller
    Jon A. Eriksen
    Gustav Gaudernack
    Cancer Immunology, Immunotherapy, 2006, 55 : 1553 - 1564
  • [49] Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
    Brunsvig, Paal F.
    Aamdal, Steinar
    Gjertsen, Marianne K.
    Kvalheim, Gunnar
    Markowski-Grimsrud, Carrie J.
    Sve, Ingunn
    Dyrhaug, Marianne
    Trachsel, Sissel
    Moller, Mona
    Eriksen, Jon A.
    Gaudernack, Gustav
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (12) : 1553 - 1564
  • [50] Activity of gemcitabine in the treatment of patients with non-small cell lung cancer: a multicenter phase II study
    Yokoyama, A
    Nakai, Y
    Yoneda, S
    Kurita, Y
    Niitani, H
    ANTI-CANCER DRUGS, 1997, 8 (06) : 574 - 581
12345